NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, Price Target & More

$40.53 +0.78 (+1.96 %)
(As of 04/26/2018 02:42 PM ET)
Previous Close$39.75
Today's Range$39.89 - $40.90
52-Week Range$11.59 - $42.79
Volume231,902 shs
Average Volume344,732 shs
Market Capitalization$798.74 million
P/E RatioN/A
Dividend YieldN/A
Beta2.39

About Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare logoTabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to enhance patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. Its cloud-based software applications include EireneRx, which is used by at-risk healthcare organizations to access its patients' medication-related information; MedWise Advisor that allows for components of EireneRx to be used independently and by a broader healthcare audience; and NiaRx, an educational software platform used in the pharmacy educational community. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Debt-to-Equity Ratio0.01%
Current Ratio1.21%
Quick Ratio1.11%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio225.17
P/E Growth8.87

Sales & Book Value

Annual Sales$134.55 million
Price / Sales6.03
Cash Flow$0.5076 per share
Price / Cash79.85
Book Value$6.86 per share
Price / Book5.91

Profitability

EPS (Most Recent Fiscal Year)($0.04)
Net Income$14.29 million
Net Margins10.63%
Return on Equity-1.96%
Return on Assets-1.21%

Miscellaneous

Employees536
Outstanding Shares20,010,000

How to Become a New Pot Stock Millionaire

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare (NASDAQ:TRHC) issued its quarterly earnings data on Monday, March, 12th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by $0.03. The business earned $43.93 million during the quarter, compared to the consensus estimate of $38.91 million. Tabula Rasa HealthCare had a negative return on equity of 1.96% and a net margin of 10.63%. The business's quarterly revenue was up 60.9% compared to the same quarter last year. During the same period last year, the company earned $0.10 earnings per share. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Tabula Rasa HealthCare.

What price target have analysts set for TRHC?

11 brokerages have issued 1 year price objectives for Tabula Rasa HealthCare's stock. Their predictions range from $16.00 to $50.00. On average, they anticipate Tabula Rasa HealthCare's share price to reach $36.2222 in the next twelve months. View Analyst Ratings for Tabula Rasa HealthCare.

Are investors shorting Tabula Rasa HealthCare?

Tabula Rasa HealthCare saw a increase in short interest during the month of March. As of March 29th, there was short interest totalling 1,060,620 shares, an increase of 47.9% from the March 15th total of 717,131 shares. Based on an average daily volume of 851,131 shares, the days-to-cover ratio is currently 1.2 days. Approximately 6.7% of the company's stock are short sold.

Who are some of Tabula Rasa HealthCare's key competitors?

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 68)
  • Dr. Orsula V. Knowlton, Co-Founder, Pres & Director (Age 49)
  • Mr. Brian W. Adams, Chief Financial Officer (Age 36)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

Press coverage about TRHC stock has been trending positive on Thursday, according to Accern Sentiment Analysis. Accern ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Tabula Rasa HealthCare earned a news sentiment score of 0.32 on Accern's scale. They also gave headlines about the company an impact score of 49.66 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $40.52.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $798.74 million and generates $134.55 million in revenue each year. The company earns $14.29 million in net income (profit) each year or ($0.04) on an earnings per share basis. Tabula Rasa HealthCare employs 536 workers across the globe.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (TRHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  100 (Vote Underperform)
Total Votes:  211
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tabula Rasa HealthCare (NASDAQ:TRHC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
11 Wall Street analysts have issued ratings and price targets for Tabula Rasa HealthCare in the last 12 months. Their average twelve-month price target is $36.2222, suggesting that the stock has a possible downside of 10.63%. The high price target for TRHC is $50.00 and the low price target for TRHC is $16.00. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.912.912.902.83
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $36.2222$36.2222$28.75$24.6667
Price Target Upside: 10.63% downside7.74% upside1.47% downside5.35% downside

Tabula Rasa HealthCare (NASDAQ:TRHC) Consensus Price Target History

Price Target History for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ:TRHC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/16/2018Chardan CapitalReiterated RatingBuy -> Buy$46.00 -> $50.00HighView Rating Details
3/13/2018CIBCReiterated RatingOutperform -> Outperform$35.00 -> $47.00MediumView Rating Details
3/13/2018OppenheimerBoost Price TargetOutperform$35.00 -> $47.00HighView Rating Details
3/13/2018William BlairReiterated RatingOutperformHighView Rating Details
3/13/2018Piper JaffrayBoost Price TargetOverweight$43.00HighView Rating Details
1/4/2018CitigroupInitiated CoverageBuyHighView Rating Details
11/1/2017First AnalysisInitiated CoverageOverweight$41.00N/AView Rating Details
10/19/2017Wells FargoBoost Price TargetMarket Perform$21.00 -> $27.00N/AView Rating Details
10/17/2017Robert W. BairdReiterated RatingOutperform$22.00 -> $30.00N/AView Rating Details
8/30/2017UBSBoost Price TargetBuy -> Buy$18.00 -> $25.00MediumView Rating Details
7/14/2017Stifel NicolausReiterated RatingBuy$16.00LowView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Tabula Rasa HealthCare (NASDAQ:TRHC) Earnings History and Estimates Chart

Earnings by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ:TRHC) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.08)($0.06)($0.07)
Q3 20181$0.15$0.15$0.15

Tabula Rasa HealthCare (NASDAQ TRHC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018($0.07)N/AView Earnings Details
3/12/2018Q4 2017$0.12$0.09$38.91 million$43.93 millionViewN/AView Earnings Details
11/6/2017Q3 2017$0.06$0.08$31.76 million$33.27 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.06$0.06$27.84 million$29.70 millionViewListenView Earnings Details
5/1/2017Q1 2017$0.06$0.04$26.00 million$27.70 millionViewListenView Earnings Details
3/13/2017Q4 2016$0.11$0.10$25.53 million$27.30 millionViewN/AView Earnings Details
11/9/2016Q316$0.03$0.06$22.35 million$24.17 millionViewListenView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Tabula Rasa HealthCare (NASDAQ:TRHC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Tabula Rasa HealthCare (NASDAQ TRHC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 45.80%
Institutional Ownership Percentage: 47.06%
Insider Trading History for Tabula Rasa HealthCare (NASDAQ:TRHC)
Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Tabula Rasa HealthCare (NASDAQ TRHC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/9/2018Calvin H KnowltonCEOSell8,000$38.69$309,520.00View SEC Filing  
3/20/2018Bruce LuehrsDirectorSell12,234$38.01$465,014.34View SEC Filing  
3/13/2018Bruce LuehrsDirectorSell16,745$37.63$630,114.35View SEC Filing  
3/9/2018Bruce LuehrsDirectorSell15,664$37.09$580,977.76View SEC Filing  
3/7/2018Calvin H KnowltonCEOSell8,000$35.59$284,720.00View SEC Filing  
3/6/2018Bruce LuehrsDirectorSell3,115$36.03$112,233.45View SEC Filing  
2/22/2018Bruce LuehrsDirectorSell252,242$34.29$8,649,378.18View SEC Filing  
2/7/2018Calvin H KnowltonCEOSell8,000$34.75$278,000.00View SEC Filing  
1/12/2018Brian W AdamsCFOBuy5,391$14.23$76,713.93View SEC Filing  
1/8/2018Calvin H KnowltonCEOSell8,000$32.75$262,000.00View SEC Filing  
12/11/2017Bruce LuehrsDirectorSell269,000$25.85$6,953,650.00View SEC Filing  
12/11/2017Growth Fund 1Q Lp OriginateMajor ShareholderSell684,180$25.85$17,686,053.00View SEC Filing  
12/8/2017Gordon TunstallDirectorSell15,000$25.85$387,750.00View SEC Filing  
12/8/2017Orsula V KnowltonInsiderSell123,000$25.97$3,194,310.00View SEC Filing  
10/18/2017Orsula V KnowltonInsiderSell8,000$26.68$213,440.00View SEC Filing  
9/13/2017Orsula V KnowltonInsiderSell8,000$22.10$176,800.00887,407View SEC Filing  
8/16/2017Calvin H KnowltonCEOSell8,000$17.21$137,680.00918,362View SEC Filing  
7/19/2017Orsula V KnowltonInsiderSell8,000$14.20$113,600.00903,407View SEC Filing  
6/14/2017Orsula V. KnowltonInsiderSell8,000$14.02$112,160.00View SEC Filing  
6/12/2017Gordon TunstallDirectorSell22,759$13.76$313,163.845,565View SEC Filing  
5/18/2017Glen R BressnerDirectorBuy7,500$11.96$89,700.0018,256View SEC Filing  
5/17/2017Orsula V KnowltonInsiderSell8,000$11.94$95,520.00919,407View SEC Filing  
10/4/2016Glen R BressnerDirectorBuy8,500$12.00$102,000.002,793,932View SEC Filing  
10/4/2016Joann M DurhamMajor ShareholderSell4,070$12.00$48,840.0012,886View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tabula Rasa HealthCare (NASDAQ TRHC) News Headlines

Source:
DateHeadline
$42.50 Million in Sales Expected for Tabula Rasa HealthCare (TRHC) This Quarter$42.50 Million in Sales Expected for Tabula Rasa HealthCare (TRHC) This Quarter
www.americanbankingnews.com - April 26 at 2:36 AM
$0.02 Earnings Per Share Expected for Tabula Rasa HealthCare (TRHC) This Quarter$0.02 Earnings Per Share Expected for Tabula Rasa HealthCare (TRHC) This Quarter
www.americanbankingnews.com - April 24 at 3:10 PM
Tabula Rasa HealthCare (TRHC) Upgraded to Strong-Buy at BidaskClubTabula Rasa HealthCare (TRHC) Upgraded to Strong-Buy at BidaskClub
www.americanbankingnews.com - April 24 at 9:58 AM
Tabula Rasa HealthCare Launches its Optimized Opioid Solution™ to Predict and Prevent Unintentional Opioid AbuseTabula Rasa HealthCare Launches its Optimized Opioid Solution™ to Predict and Prevent Unintentional Opioid Abuse
finance.yahoo.com - April 24 at 9:17 AM
Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call onTabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on
www.nasdaq.com - April 23 at 4:31 PM
Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 2018Tabula Rasa Healthcare to Announce First Quarter 2018 Operating Results and Host Conference Call on Tuesday, May 8, 2018
finance.yahoo.com - April 23 at 4:31 PM
Tabula Rasa Healthcares SinfoníaRx Publishes Annual Performance ReportTabula Rasa Healthcare's SinfoníaRx Publishes Annual Performance Report
globenewswire.com - April 23 at 9:03 AM
Tabula Rasa Healthcare’s SinfoníaRx Publishes Annual Performance ReportTabula Rasa Healthcare’s SinfoníaRx Publishes Annual Performance Report
finance.yahoo.com - April 23 at 9:03 AM
Tabula Rasa HealthCare (TRHC) Receives New Coverage from Analysts at Chardan CapitalTabula Rasa HealthCare (TRHC) Receives New Coverage from Analysts at Chardan Capital
www.americanbankingnews.com - April 19 at 7:29 PM
Tabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE OrganizationsTabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE Organizations
finance.yahoo.com - April 16 at 9:12 AM
Tabula Rasa HealthCare Inc (TRHC) Short Interest UpdateTabula Rasa HealthCare Inc (TRHC) Short Interest Update
www.americanbankingnews.com - April 14 at 2:27 AM
Tabula Rasa HealthCare (TRHC) Price Target Raised to $18.00 at Robert W. BairdTabula Rasa HealthCare (TRHC) Price Target Raised to $18.00 at Robert W. Baird
www.americanbankingnews.com - April 12 at 8:29 PM
Tabula Rasa HealthCare Inc (TRHC) Receives Average Rating of "Buy" from BrokeragesTabula Rasa HealthCare Inc (TRHC) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 11 at 7:35 PM
Tabula Rasa HealthCare Inc (TRHC) CEO Sells $309,520.00 in StockTabula Rasa HealthCare Inc (TRHC) CEO Sells $309,520.00 in Stock
www.americanbankingnews.com - April 10 at 7:13 PM
 Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) Will Post Quarterly Sales of $42.50 Million Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) Will Post Quarterly Sales of $42.50 Million
www.americanbankingnews.com - April 9 at 2:34 AM
Zacks: Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) to Post $0.02 Earnings Per ShareZacks: Brokerages Expect Tabula Rasa HealthCare Inc (TRHC) to Post $0.02 Earnings Per Share
www.americanbankingnews.com - April 7 at 5:22 PM
Tabula Rasa HealthCare (TRHC) Says CMS Changes to Medicare Part D Provide Potential Expansion of its Medication Therapy Management ServicesTabula Rasa HealthCare (TRHC) Says CMS Changes to Medicare Part D Provide Potential Expansion of its Medication Therapy Management Services
www.streetinsider.com - April 5 at 4:32 PM
CMS Changes to Medicare Part D Provide Potential Expansion of TRHC Medication Therapy Management Services for Medicare Advantage PlansCMS Changes to Medicare Part D Provide Potential Expansion of TRHC Medication Therapy Management Services for Medicare Advantage Plans
finance.yahoo.com - April 4 at 4:56 PM
Philadelphia Media Network Ranks Tabula Rasa HealthCare No. 6 on 2018 Top Places to WorkPhiladelphia Media Network Ranks Tabula Rasa HealthCare No. 6 on 2018 Top Places to Work
finance.yahoo.com - April 3 at 4:36 PM
Tabula Rasa HealthCare (TRHC) Research Coverage Started at CitigroupTabula Rasa HealthCare (TRHC) Research Coverage Started at Citigroup
www.americanbankingnews.com - March 30 at 4:32 PM
$42.50 Million in Sales Expected for Tabula Rasa HealthCare Inc (TRHC) This Quarter$42.50 Million in Sales Expected for Tabula Rasa HealthCare Inc (TRHC) This Quarter
www.americanbankingnews.com - March 23 at 3:06 AM
Tabula Rasa HealthCare Inc (TRHC) Director Sells $465,014.34 in StockTabula Rasa HealthCare Inc (TRHC) Director Sells $465,014.34 in Stock
www.americanbankingnews.com - March 22 at 10:20 PM
Tabula Rasa HealthCare (TRHC) Upgraded by BidaskClub to BuyTabula Rasa HealthCare (TRHC) Upgraded by BidaskClub to Buy
www.americanbankingnews.com - March 22 at 9:48 AM
Tabula Rasa HealthCare to Provide Innovative Medication Risk Mitigation Technology to National Provider GroupTabula Rasa HealthCare to Provide Innovative Medication Risk Mitigation Technology to National Provider Group
finance.yahoo.com - March 20 at 9:34 AM
Piper Jaffray Companies Boosts Tabula Rasa HealthCare (TRHC) Price Target to $43.00Piper Jaffray Companies Boosts Tabula Rasa HealthCare (TRHC) Price Target to $43.00
www.americanbankingnews.com - March 18 at 11:25 AM
Tabula Rasa HealthCare Inc (TRHC) Receives Consensus Recommendation of "Buy" from BrokeragesTabula Rasa HealthCare Inc (TRHC) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - March 17 at 7:38 PM
Tabula Rasa HealthCare (TRHC) Downgraded by Zacks Investment Research to SellTabula Rasa HealthCare (TRHC) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - March 17 at 8:12 AM
Tabula Rasa HealthCare (TRHC) Given New $50.00 Price Target at Chardan CapitalTabula Rasa HealthCare (TRHC) Given New $50.00 Price Target at Chardan Capital
www.americanbankingnews.com - March 16 at 9:54 PM
William Blair Comments on Tabula Rasa HealthCare Incs Q1 2018 Earnings (TRHC)William Blair Comments on Tabula Rasa HealthCare Inc's Q1 2018 Earnings (TRHC)
www.americanbankingnews.com - March 16 at 7:44 AM
Oppenheimer Analysts Reduce Earnings Estimates for Tabula Rasa HealthCare Inc (TRHC)Oppenheimer Analysts Reduce Earnings Estimates for Tabula Rasa HealthCare Inc (TRHC)
www.americanbankingnews.com - March 16 at 7:44 AM
THRC’s CEO Calvin H. Knowlton, PhD Interviewed on NPR’s It’s Your HealthTHRC’s CEO Calvin H. Knowlton, PhD Interviewed on NPR’s It’s Your Health
finance.yahoo.com - March 15 at 9:12 AM
Tabula Rasa HealthCare Inc (TRHC) Director Bruce Luehrs Sells 16,745 SharesTabula Rasa HealthCare Inc (TRHC) Director Bruce Luehrs Sells 16,745 Shares
www.americanbankingnews.com - March 14 at 7:29 PM
Tabula Rasa HealthCare to Participate in the Oppenheimer 28th Annual Healthcare ConferenceTabula Rasa HealthCare to Participate in the Oppenheimer 28th Annual Healthcare Conference
finance.yahoo.com - March 14 at 10:18 AM
Tabula Rasa HealthCare (TRHC) Reports Q4 EPS of $0.09, Beats on RevenuesTabula Rasa HealthCare (TRHC) Reports Q4 EPS of $0.09, Beats on Revenues
www.streetinsider.com - March 13 at 6:27 PM
Tabula Rasa HealthCare (TRHC) Price Target Raised to $47.00Tabula Rasa HealthCare (TRHC) Price Target Raised to $47.00
www.americanbankingnews.com - March 13 at 3:52 PM
Tabula Rasa HealthCare (TRHC) Given "Outperform" Rating at CIBCTabula Rasa HealthCare (TRHC) Given "Outperform" Rating at CIBC
www.americanbankingnews.com - March 13 at 3:45 PM
William Blair Reaffirms Outperform Rating for Tabula Rasa HealthCare (TRHC)William Blair Reaffirms Outperform Rating for Tabula Rasa HealthCare (TRHC)
www.americanbankingnews.com - March 13 at 1:38 PM
Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani to Receive American Pharmacists Association’s Hugo H. Schaefer AwardTabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani to Receive American Pharmacists Association’s Hugo H. Schaefer Award
finance.yahoo.com - March 13 at 9:37 AM
Bruce Luehrs Sells 15,664 Shares of Tabula Rasa HealthCare Inc (TRHC) StockBruce Luehrs Sells 15,664 Shares of Tabula Rasa HealthCare Inc (TRHC) Stock
www.americanbankingnews.com - March 12 at 7:38 PM
Tabula Rasa HealthCare (TRHC) Announces  Earnings ResultsTabula Rasa HealthCare (TRHC) Announces Earnings Results
www.americanbankingnews.com - March 12 at 7:36 PM
Tabula Rasa HealthCare misses by $0.08, beats on revenueTabula Rasa HealthCare misses by $0.08, beats on revenue
seekingalpha.com - March 12 at 5:36 PM
Tabula Rasa Healthcare, Inc. to Host Earnings CallTabula Rasa Healthcare, Inc. to Host Earnings Call
finance.yahoo.com - March 12 at 5:36 PM
Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2017 Operating ResultsTabula Rasa HealthCare Announces Fourth Quarter and Full Year 2017 Operating Results
finance.yahoo.com - March 12 at 5:36 PM
Tabula Rasa Healthcare misses 4Q profit forecastsTabula Rasa Healthcare misses 4Q profit forecasts
finance.yahoo.com - March 12 at 5:36 PM
Manufacturing Figures Out Next Week in CanadaManufacturing Figures Out Next Week in Canada
www.baystreet.ca - March 9 at 5:37 PM
Tabula Rasa HealthCare Inc (TRHC) Director Sells $112,233.45 in StockTabula Rasa HealthCare Inc (TRHC) Director Sells $112,233.45 in Stock
www.americanbankingnews.com - March 8 at 7:06 PM
Calvin H. Knowlton Sells 8,000 Shares of Tabula Rasa HealthCare Inc (TRHC) StockCalvin H. Knowlton Sells 8,000 Shares of Tabula Rasa HealthCare Inc (TRHC) Stock
www.americanbankingnews.com - March 8 at 6:45 PM
Tabula Rasa HealthCare (TRHC) Lowered to Hold at Zacks Investment ResearchTabula Rasa HealthCare (TRHC) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - March 7 at 4:58 PM
Tabula Rasa HealthCare Inc (TRHC) Expected to Post Quarterly Sales of $39.06 MillionTabula Rasa HealthCare Inc (TRHC) Expected to Post Quarterly Sales of $39.06 Million
www.americanbankingnews.com - March 6 at 5:50 AM
Ranger Investment Management L.P. Boosts Position in Tabula Rasa HealthCare Inc (TRHC)Ranger Investment Management L.P. Boosts Position in Tabula Rasa HealthCare Inc (TRHC)
www.americanbankingnews.com - March 5 at 3:37 PM

SEC Filings

Tabula Rasa HealthCare (NASDAQ:TRHC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tabula Rasa HealthCare (NASDAQ:TRHC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tabula Rasa HealthCare (NASDAQ TRHC) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.